5
Hold
Average of 2 AIs
→ Unchanged from previous
Last Updated: 5 Mar 2026, 03:25 pm IST | Report Date: Feb 14, 2026

Saraswati Saree Depot Limited Stock Analysis

SSDL NSE 🇮🇳 India
5.0
ChatGPT
Hold
5.0
Claude
Hold

Saraswati Saree Depot Limited (SSDL) is a India-based company listed on NSE. This AI-powered analysis provides investment insights based on quarterly earnings reports and financial performance metrics.

Share Share Share

Overall verdict: Hold (neutral) for a 6-12 month horizon because the filing is governance-compliant but fundamentally data-light. The Board approved Q3 FY2025-26 and 9M results for the period ended 31-Dec-2025 on 14-Feb-2026, and the statements were prepared under IND AS with a statutory auditor limited review. However, core performance fields such as revenue, EBITDA, PAT, EPS, margins, cash flow, debt, and return ratios are all reported as null, so earnings quality and trend strength cannot be validated. With no quantified operating or balance-sheet disclosure in this extract, directional conviction on growth or valuation re-rating remains limited.

Based on: Saraswati Saree Depot Limited - Financial Results (14/2/2026) (Feb 14, 2026)

AI Investment Score & Analysis

+ Key Strengths

Board approval of unaudited Q3 and 9M FY2025-26 results was completed on 14-Feb-2026 for the reporting period ended 31-Dec-2025, indicating timely quarterly closure.
Financials were prepared under Indian Accounting Standards (IND AS), improving comparability and accounting consistency.
Auditor opinion is explicitly a "Limited Review," providing external procedural assurance on the quarter's unaudited numbers.
The company maintained exchange compliance disclosures under SEBI LODR and is listed on both NSE (SSDL) and BSE (544230), supporting market access and reporting visibility.
The Board meeting had defined governance timestamps (4:00 PM to 4:35 PM on 14-Feb-2026), evidencing formal process discipline.

- Key Risks

Earnings quality cannot be assessed because revenue_from_operations, total_revenue, EBITDA, EBIT, PAT, EPS, and margin metrics are all null in the extract.
Cash-flow sustainability is unassessable as operating_cash_flow, free_cash_flow, capex, financing_cash_flow, and investing_cash_flow are all null.
Financial health visibility is weak since debt, equity, total_assets, current_ratio, quick_ratio, debt_to_equity, and interest_coverage are all null.
No specific risk factors were disclosed in the filing text, limiting transparency on concentration, commodity, regulatory, or competitive exposures.
No forward-looking statements, project announcements, capex plans, partnerships, acquisitions, or expansion guidance were provided, reducing catalyst visibility for the next 2-4 quarters.

Forward Outlook

Strategically, the reported quarter shows only one concrete action: Board approval of Q3/9M unaudited results on 14-Feb-2026 under IND AS with limited review. The extract does not mention any new initiatives such as capacity expansion, product launches, partnerships, acquisitions, or capex programs. It also provides no formal forward guidance or pipeline catalysts for the coming 2-4 quarters. Based strictly on available data, momentum across key segments is indeterminate rather than clearly accelerating or decelerating, so near-term performance expectations remain neutral pending fuller financial disclosures.

Detailed AI Analysis by Provider

5.0
OpenAI ChatGPT Hold
codex-cli (OpenAI Codex)

Overall verdict: Hold (neutral) for a 6-12 month horizon because the filing is governance-compliant but fundamentally data-light. The Board approved Q3 FY2025-26 and 9M results for the period ended 31-Dec-2025 on 14-Feb-2026, and the statements were prepared under IND AS with a statutory auditor limited review. However, core performance fields such as revenue, EBITDA, PAT, EPS, margins, cash flow, debt, and return ratios are all reported as null, so earnings quality and trend strength cannot be validated. With no quantified operating or balance-sheet disclosure in this extract, directional conviction on growth or valuation re-rating remains limited.

Forward Outlook

Strategically, the reported quarter shows only one concrete action: Board approval of Q3/9M unaudited results on 14-Feb-2026 under IND AS with limited review. The extract does not mention any new initiatives such as capacity expansion, product launches, partnerships, acquisitions, or capex programs. It also provides no formal forward guidance or pipeline catalysts for the coming 2-4 quarters. Based strictly on available data, momentum across key segments is indeterminate rather than clearly accelerating or decelerating, so near-term performance expectations remain neutral pending fuller financial disclosures.

Strengths

Board approval of unaudited Q3 and 9M FY2025-26 results was completed on 14-Feb-2026 for the reporting period ended 31-Dec-2025, indicating timely quarterly closure.
Financials were prepared under Indian Accounting Standards (IND AS), improving comparability and accounting consistency.
Auditor opinion is explicitly a "Limited Review," providing external procedural assurance on the quarter's unaudited numbers.
The company maintained exchange compliance disclosures under SEBI LODR and is listed on both NSE (SSDL) and BSE (544230), supporting market access and reporting visibility.
The Board meeting had defined governance timestamps (4:00 PM to 4:35 PM on 14-Feb-2026), evidencing formal process discipline.

Risks

Earnings quality cannot be assessed because revenue_from_operations, total_revenue, EBITDA, EBIT, PAT, EPS, and margin metrics are all null in the extract.
Cash-flow sustainability is unassessable as operating_cash_flow, free_cash_flow, capex, financing_cash_flow, and investing_cash_flow are all null.
Financial health visibility is weak since debt, equity, total_assets, current_ratio, quick_ratio, debt_to_equity, and interest_coverage are all null.
No specific risk factors were disclosed in the filing text, limiting transparency on concentration, commodity, regulatory, or competitive exposures.
No forward-looking statements, project announcements, capex plans, partnerships, acquisitions, or expansion guidance were provided, reducing catalyst visibility for the next 2-4 quarters.
5.0
Anthropic Claude Hold
claude-cli (Claude Code)

The analysis is severely constrained by the complete absence of quantitative financial data across all critical metrics including revenue, profitability, cash flows, balance sheet items, and operational ratios. The extracted data contains only procedural information about a Board meeting held on February 14, 2026, approving unaudited Q3 FY2025-26 results with limited review from auditors, but provides no actual financial figures. Without visibility into revenue growth, margin trends, debt levels, cash generation, or return ratios, it is impossible to assess earnings quality, financial health, or operational efficiency. The neutral score reflects information inadequacy rather than fundamental quality, making any investment decision premature until actual financial statements become available.

Forward Outlook

The report provides no information on strategic initiatives, new projects, capacity expansions, product launches, or partnerships undertaken during Q3 FY2025-26. No forward guidance, pipeline projects, capex commitments, or expansion plans for the next 2-4 quarters were disclosed in the extracted data. Without visibility into revenue momentum, segment-wise performance, or management commentary on market conditions, it is not possible to assess whether growth is accelerating, stable, or decelerating. Investors should await the full financial statement release with complete income statement, balance sheet, cash flow data, and management discussion analysis before making any investment decisions. Until quantitative performance metrics and strategic outlook become available, the company's near-term trajectory and investment merit remain indeterminate.

Strengths

The company maintains regulatory compliance with timely Board approval of Q3 FY2025-26 financial results on February 14, 2026, and adherence to SEBI Listing Obligations and Disclosure Requirements Regulations, 2015
Financial results were prepared under Indian Accounting Standards (IND AS) as per Companies (Indian Accounting Standards) Rules, 2015, indicating adoption of internationally recognized accounting frameworks
The results underwent limited review by statutory auditors, providing a basic level of external validation and oversight of the reported financials
Dual listing on both NSE (symbol: SSDL) and BSE (scrip code: 544230) provides enhanced liquidity options and broader investor accessibility

Risks

Complete absence of quantitative financial data prevents assessment of revenue growth trajectory, profitability trends, or competitive positioning in the saree retail segment
No cash flow metrics disclosed makes it impossible to evaluate liquidity position, debt servicing capability, free cash flow generation, or capex funding requirements
Lack of balance sheet data obscures visibility into leverage levels, working capital efficiency, asset quality, or capital structure sustainability
Missing operational metrics including EBITDA margins, inventory turnover, receivables quality, and return ratios prevents evaluation of operational efficiency and management effectiveness
No management discussion or forward-looking statements provided limits understanding of strategic direction, growth initiatives, market challenges, or upcoming catalysts
The brief 35-minute Board meeting duration may indicate limited depth of discussion on business strategy, risk assessment, or operational performance review

Score History

Score Timeline

Quarterly Report News Event

All Scores

Date Report Score Sentiment AI
Mar 5, 2026 Saraswati Saree Depot Limited - Financial Results (14/2/2026) 5.0 Hold ChatGPT
Feb 28, 2026 Saraswati Saree Depot Limited - Financial Results (14/2/2026) 5.0 Hold Claude

Related Stocks on NSE

Sakuma Exports Limited
SAKUMA
4.0
Navkar Urbanstructure Limited
NAVKARURB
4.0
Kronox Lab Sciences Limited
KRONOX
7.0
Orient Technologies Limited
ORIENTTECH
4.5
CIE Automotive India Limited
CIEINDIA
7.5
Healthcare Global Enterprises Limited
HCG
5.0
IRIS RegTech Solutions Limited
IRIS
6.0
Rushabh Precision Bearings Limited
RUSHABEAR

Frequently Asked Questions

What is the AI Stock Score?

The AI Stock Score is a composite rating from 0-10 generated by analyzing quarterly earnings reports using three leading AI models (Google Gemini, Anthropic Claude, and OpenAI ChatGPT). Each AI independently evaluates financial performance, growth prospects, risks, and market positioning to provide an objective investment perspective.

How should I interpret Buy/Hold/Sell ratings?

Buy (7.0-10.0): Strong fundamentals and positive outlook. Hold (4.0-6.9): Mixed signals, suitable for existing positions. Sell (0-3.9): Deteriorating fundamentals or significant risks. These are AI-generated opinions for informational purposes only, not investment advice.

How is the composite score calculated?

The composite score is the mathematical average of the latest scores from each AI provider. For example, if Gemini rates 7.5, Claude rates 4.5, and ChatGPT rates 6.0, the composite score would be (7.5+4.5+6.0)/3 = 6.0. This multi-AI approach reduces bias from any single model.

How often are scores updated?

Scores are automatically generated within hours of quarterly earnings results being published on NSE. The system monitors earnings announcements 4 times daily and processes new reports immediately. Check the "Last Updated" date at the top of this page for the most recent analysis timestamp.

Is this financial advice?

No. This is AI-generated analysis for informational and educational purposes only. MarketsHost is not a SEBI-registered Research Analyst or Investment Adviser. AI models can produce inaccurate results. Always consult a qualified financial advisor and conduct your own due diligence before making investment decisions.